GLP-1 receptor agonists for hidradenitis suppurativa: Navigating benefits, risks, and ethical considerations

被引：1
|
作者：
Gu, Yaron [1 ,2 ]
Sebaratnam, Deshan F. [1 ,2 ]
机构：
[1] Univ New South Wales, Fac Med & Hlth, Kensington, NSW, Australia
[2] Liverpool Hosp, Dept Dermatol, Liverpool, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年 / 63卷 / 05期
关键词：
hidradenitis suppurativa; GLP-1 receptor agonist;
D O I：
10.1111/ijd.17108
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e100 / e101
页数：2
相关论文
共 50 条
  • [1] Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?
    Strong, Jennifer
    Driscoll, Marcia S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (02) : 175 - 182
  • [2] Therapeutic potential of GLP-1 Agonists for Hidradenitis Suppurativa
    Henry, Tanya
    Cahn, Brian
    Haber, Roger
    Landers, John T.
    Berger-Fleishman, Reed
    Alam, Murad
    Hoyer, Sheryl
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (12) : 1543 - 1544
  • [3] GLP-1 Agonists in Patients with Hidradenitis Suppurativa: A Case Series
    Rames, Melissa M.
    Alavi, Afsaneh
    Aghazadeh, Nessa
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [4] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Xie, Yan
    Choi, Taeyoung
    Al-Aly, Ziyad
    NATURE MEDICINE, 2025, : 951 - 962
  • [5] Cardiovascular safety and benefits of GLP-1 receptor agonists
    Dalsgaard, Niels B.
    Bronden, Andreas
    Vilsboll, Tina
    Knop, Filip K.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 351 - 363
  • [6] GLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations
    Vidal, Savanna I.
    Menta, Nikita
    Nussbaum, Dillon
    Friedman, Adam
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (11) : 1026 - 1027
  • [7] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection
    Laura C. Page
    Michael Freemark
    Current Obesity Reports, 2020, 9 : 391 - 401
  • [8] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection
    Page, Laura C.
    Freemark, Michael
    CURRENT OBESITY REPORTS, 2020, 9 (04) : 391 - 401
  • [9] Risk of Suicide From GLP-1 Agonists: Weighing Risks and Benefits
    Nierenberg, Andrew A.
    PSYCHIATRIC ANNALS, 2024, 54 (09) : e246 - e246
  • [10] Evaluating the benefits of the early use of GLP-1 receptor agonists
    Zushin, Peter-James H.
    Wu, Joseph C.
    LANCET, 2025, 405 (10474): : 181 - 183
12345